Successful long-term (22 year) treatment of limited scleroderma using therapeutic plasma exchange: Is blood rheology the key?
- 23 June 2016
- journal article
- case report
- Published by SAGE Publications in Clinical Hemorheology and Microcirculation
- Vol. 65 (2) , 131-136
Abstract
While a number of studies have shown short-term beneficial effects of therapeutic plasma exchange (TPE) for treating systemic scleroderma (SSc), there have been no reports on the very long-term usage of TPE as the sole systemic treatment intervention. We report the case of a male patient, originally diagnosed with limited systemic scleroderma (lcSSc) in early 1990, who has been undergoing regular plasmapheresis treatments for more than 22 years, beginning in late 1993. Prior to commencing treatment, the patient exhibited symptoms including severe gastro esophageal reflux disease (GERD) with esophagitis, frequent Raynaud’s attacks, reduced lung function, and chronic chilling. With the exception of mild residual Raynaud’s, all of the patient’s symptoms reversed after three years of regular TPE treatments and he remains in complete remission. While the typical explanation for the therapeutic benefits seen with TPE focuses on temporary reduction of circulating antibodies or other pathogenic factors, we propose instead an explanation based on abnormal blood rheology as a novel disease pathogenesis model for SSc.Keywords
This publication has 15 references indexed in Scilit:
- Endothelial mechanosensors of shear stress as regulators of atherogenesisCurrent Opinion in Lipidology, 2012
- High N‐terminal pro–brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosisArthritis & Rheumatism, 2007
- Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group databaseAnnals of the Rheumatic Diseases, 2007
- Isolated pulmonary hypertension in diffuse cutaneous systemic sclerosis successfully treated with long-term plasma exchange: CASE REPORTScandinavian Journal of Rheumatology, 2000
- Plasma exchange in the treatment of nonadvanced stages of progressive systemic sclerosisJournal of Clinical Apheresis, 1987
- Plasma exchange: A controlled study of the effect in patients with Raynaud's phenomenon and sclerodermaJournal of Clinical Apheresis, 1983
- Haemorrheological response to plasma exchange in Raynaud's syndrome.BMJ, 1979
- Endothelial injury in scleroderma.Journal of Experimental Medicine, 1979
- Blood hyperviscosity with reduced skin blood flow in sclerodermaAnnals of the Rheumatic Diseases, 1977
- Blood Viscosity, Plasma Proteins, and Raynaud SyndromeArchives of Surgery, 1975